Site Therapeutics is a biotechnology company based in South San Francisco, CA, specializing in high-throughput functional genomics to map the genetic determinants of immune cell function down to the nucleotide level. The company aims to develop novel drugs by leveraging advanced genomic technologies to fine-tune immune cell responses, addressing various human health conditions. Site Therapeutics generates revenue through the research and development of these innovative therapeutic solutions, employing a team of scientists and researchers dedicated to advancing immunology and genomics.